Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use PIASKY safely and effectively. See full prescribing information for PIASKY. PIASKY (crovalimab-akkz) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2024
Medication labelWhy this: Advisory · dailymed-prescription
PIASKY is indicated for the treatment of adult and pediatric patients 13 years and older with paroxysmal nocturnal hemoglobinuria (PNH) and body weight of at least 40 kg.
- generic_name
- crovalimab
- product_names
- Crovalimab
- ndc
- 50242-115, 50242-115-01
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en